Press release
Global Acromegaly Treatment Industry Outlook To Witness The Lucrative Growth US$ 2.1Bn by 2031| Demand, Pipeline Drugs & Forecasts
Acromegaly Treatment Market
The Acromegaly Treatment Market Report by DataM Intelligence offers comprehensive insights into the latest market trends, key growth drivers, and emerging challenges. Crafted to support smarter and faster decision-making, our reports blend in-depth data analysis with expert insights. At DataM Intelligence, we simplify complex market dynamics into actionable strategies empowering businesses to remain competitive, scale confidently, and capitalize on the right opportunities in an ever-evolving landscape.
Unlock exclusive insights with our detailed sample report (Corporate Email ID gets priority access): https://datamintelligence.com/download-sample/acromegaly-treatment-market?kb
Acromegaly Treatment Market Overview
Acromegaly is a rare hormonal disorder that results from excess growth hormone (GH) in the body, typically caused by a benign tumor (adenoma) on the pituitary gland. Treatments aim to reduce GH production, remove the tumor, or block GH effects and may include surgery, medication, and radiation therapy.
Research Methodology:
The global Acromegaly Treatment Market research report is based on a combination of primary and secondary data sources. The study carefully analyzes various factors influencing the industry, including government regulations, market dynamics, competitive landscape, historical trends, current conditions, and technological progress. It also evaluates future developments, related industry trends, market volatility, growth prospects, potential obstacles, and emerging challenges.
Segment Covered in the Acromegaly Treatment Market:
By Disease Type: Ectopic Acromegaly, Pseudo Acromegaly
By Treatment: Medication (Somatostatin analogs, Dopamine Agonists, Growth hormone receptor antagonists, Others), Surgery, Radiation Therapy
Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/acromegaly-treatment-market?kb
List of the Key Players in the Acromegaly Treatment Market:
Recordati Rare Diseases, Pfizer Inc., Validus Pharmaceuticals LLC, Ipsen Pharma, Crinetics Pharmaceuticals, Inc., Amryt Pharma plc, Debiopharm, ADVANZ PHARMA, Novartis Pharmaceuticals Corporation and Amolyt Pharma among others.
Industry Development:
On December 5, 2022, the European Commission (EC) approved Mycapssa for continued treatment of acromegaly in the European Union. This approval applies to patients who have responded to and are stable on octreotide or lanreotide therapy. According to Amryt, a global commercial-stage biopharmaceutical company focused on rare diseases, Mycapssa is already approved in the United States for maintenance therapy in patients who have shown a positive response to injectable octreotide or lanreotide.
On March 16, 2022, Ipsen announced its investment in a state-of-the-art electronic autoinjector for Somatuline Autogel (Somatuline Depot in the U.S.), aimed at advancing innovation and improving patient experience during administration. Ipsen will collaborate with Phillips-Medisize, a global expert in drug delivery design and manufacturing, as part of a broader initiative that also includes expanding Ipsen's manufacturing facility in Signes, France.
Regional Analysis for Acromegaly Treatment Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
The Report Includes:
➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.
➡ Top-down and bottom-up approach for regional analysis
➡ Go-to-market Strategy.
➡ Neutral perspective on the market performance.
➡ Customized regional/country reports as per request and country level analysis.
➡ Potential & niche segments and regions exhibiting promising growth covered.
People Also Ask:
➠ What are the global sales, production, consumption, imports, and exports in the Acromegaly Treatment market?
➠ Who are the top manufacturers, and what are their capacity, production, sales, pricing, and revenue stats?
➠ What key opportunities and challenges do vendors face in the Acromegaly Treatment industry?
➠ Which product types, applications, or end-users are driving market growth, and what is their market share?
➠ What are the major growth drivers and restraints of the Acromegaly Treatment market?
Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription?kb
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Acromegaly Treatment Industry Outlook To Witness The Lucrative Growth US$ 2.1Bn by 2031| Demand, Pipeline Drugs & Forecasts here
News-ID: 4081171 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Tendinitis Treatment Market Revenues Anticipated to Increase Significantly Due t …
Tendinitis Treatment Market is expected to grow at a CAGR of 4% during the forecast period 2024-2031.
The Tendinitis Treatment Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. By combining qualitative and quantitative research methodologies, the firm delivers in-depth…
Vein Finders Market Overview Size US$ 346.6 Mn by 2031, CAGR, Key Developments T …
The Global Vein Finders Market reached US$ 244.50 million in 2023 and is expected to reach US$ 346.6 million by 2031, growing at a CAGR of 4.5% during the forecast period 2024-2031.
The Vein Finders Market Report by DataM Intelligence offers comprehensive insights into the latest market trends, key growth drivers, and emerging challenges. Crafted to support smarter and faster decision-making, our reports blend in-depth data analysis with expert insights. At…
Activated Charcoal Supplements Market | Natural Detox Trend Fuels Global Growth …
Global Activated Charcoal Supplements Market reached US$ 5.54 billion in 2022 and is expected to reach US$ 8.75 billion by 2031, growing with a CAGR of 5.89% during the forecast period 2024-2031.
The Activated Charcoal Supplements Market receives exhaustive analysis from DataM Intelligence, delivering stakeholders essential market data, emerging industry patterns, and strategic business intelligence. This in-depth research explores the competitive landscape in detail, evaluating market leaders across multiple dimensions including…
Ambulatory Surgical Centers Market Projected for Steady Growth with High Potenti …
Ambulatory Surgical Centers Market size was valued at US$ 82,938.67 million in 2022 and is estimated to reach US$ 149,758.34 million by 2031, growing at a CAGR of 8.26% during the forecast period 2024-2031.
The Ambulatory Surgical Centers Market report by DataM Intelligence provides comprehensive insights and analysis on key market trends, growth opportunities, and emerging challenges. With a commitment to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed…
More Releases for Acromegaly
Acromegaly - Drug Pipeline Landscape, 2022
Acromegaly is a rare hormonal condition that results from an excess amount of growth hormone (GH) in the body. The extra amount of GH causes excess growth in the bones and soft tissues of the body. Children with the condition can grow to abnormal heights.
The most common cause of acromegaly is a tumor in your pituitary gland called a pituitary adenoma that causes pituitary gland to release excess growth hormone…
Acromegaly Treatment Market Report Up to 2031
Visiongain has published a new report on Acromegaly Treatment Market Report to 2031: Forecasts By Disease Type (Ectopic Acromegaly and Pseudo Acromegaly), By Drug Class (Somatostatin Analogs (SSAs) (Somatuline Depot and Other SSAs), Dopamine Agonists (Bromocriptine Mesylate and Other Dopamine Agonists), and Growth Hormone Receptor Antagonist (Somavert)), By Route of Administration (Oral and Parenteral), and By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online pharmacies) PLUS COVID-19 Recovery Scenarios.
COVID-19 Impact…
Global Acromegaly Market Report Forecast to 2027
Acromegaly is a rare hormonal disease that occurs when the body produces too much growth hormone (GH). The excess GH promotes excessive development in the body's bones and soft tissues. The syndrome causes children to grow to very tall heights. They may also have a disproportionately large bone structure. Acromegaly is a condition that mostly affects the arms, legs, and face.
Get sample copy of this report @ …
Global Acromegaly Market Insights, Forecast
Acromegaly is a hormonal disorder that develops when your pituitary gland produces too much growth hormone during adulthood. When this happens, your bones increase in size, including those of your hands, feet and face. Acromegalyusually affects middle-aged adults. The global Acromegaly market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The…
Acromegaly Treatment Market Opportunity Analysis, 2018-2026
Acromegaly is a rare disorder caused due to the excess production of growth hormone by the pituitary gland, affecting a patient’s physical appearance and internal organs. It is usually caused by benign pituitary tumor (adenoma), however, in rare cases acromegaly symptoms can be observed due to ineffective control of growth hormone-secreting cells by hypothalamus. Abnormal enlargement of hands, arms, feet, legs, and head, and gradual changes in facial features such…
Global Acromegaly Treatment Market (Ectopic Acromegaly & Pseudo Acromegaly)Diagn …
Global acromegaly treatment market was valued at approximately USD +664.0 Million in 2016 and is expected to generate revenue of around USD +838.0 Million by the end of 2022, growing at a CAGR of around +3.94% between 2017 and 2022. There are various symptoms experienced by the patient like the protruded jaw, increased the size of limbs, the spacing between teeth of lower jaw and others. Conditions like hypertension, diabetes,…
